REMEDY : BNSSG referral pathways & Joint Formulary


Home > Adults > Respiratory >

myCOPD App

Checked: 23-05-2022 by Vicky Ryan Next Review: 23-05-2023

Overview

my COPD (App )                                                                                   

My COPD helps people with COPD (Chronic Obstructive Pulmonary Disease) to better manage their condition. It can be used to perfect inhaler technique, improve breathing, reduce exacerbations, track medication and more.

Inclusion and Exclusion Criteria

Most patients are appropriate for referral to the myCOPD app and COPD Digital Champion Service. However, palliative patients are the main group of patients who are not appropriate, alongside patients who are not able to speak and read English.

Patients do not need to be confident with technology, so long as they have access to a device (tablet, mobile phone or PC) and the internet. There has been a significant increase in the number of people becoming digitally literate because of Covid-19 and those who less confident in using technology will be supported by the COPD Digital Champion team to become comfortable and independent in using the app.

COPD Digital Champion Service

The COPD Digital Champion Service has been set up to support patient enrolment and use of the app. The Digital Health Champions (DHCs) are based within the local respiratory teams in NBT, UHBW and Sirona.

The benefits of the service are:

  • Improved self-management support for your patients with COPD.
  • Subsequent reductions needed in healthcare visits.
  • Support from the DHC team in coaching your patients to achieve agreed clinical goals.
  • In primary care, clinicians can access the ‘myCOPD Clinical Dashboard’ and have the ability to understand how well patients are managing their condition.

How to sign up and start to refer your patients to the COPD Digital Champion Service

In the acute and community settings, there is no need to sign up because the organisations have signed the Data Protection Impact Assessment (DPIA). Please refer to the ‘Referral section below’.

In primary care, practices will need to sign up individually. This will entail signing a Data Protection Impact Assessment and setting up an SMS campaign. For further detail, see the COPD Digital Champion Service Primary Care Implementation Toolkit on TeamNet

If you are interested in signing up, please contact jenni.rutherford@uhbw.nhs.uk.

Referral

At the time of referral, clinicians can request specific goals to be targeted. Patients who are registered onto the system by the COPD Digital Champion team can then be supported to activate their account and work towards standard goals, agreed with the referring clinician if appropriate i.e. complete your inhaler videos and work through your education as a starting point.

From primary care

If your practice has signed up, please refer via email.

All practice clinicians that review patients will be able to offer the app at clinical review (i.e. for exacerbation, medication review) and refer directly to the COPD Digital Champion Service via the service email address: nbn-tr.mycopd.nbt@nhs.net. Reference the patient’s name, NHS number and telephone number.

From Sirona care and health and University Hospitals Bristol and Weston

Refer directly to the COPD Digital Champion Service via the service email address: nbn-tr.mycopd.nbt@nhs.net. Reference the patient’s name, NHS number and telephone number.

From North Bristol Trust

Refer directly to the COPD Digital Champion Service via ICE or alternatively refer via the service email address: nbn-tr.mycopd.nbt@nhs.net. Reference the patient’s name, NHS number and telephone number.

 



Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.

Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.